CYP cynata therapeutics limited

Ann: Study of Cymerus MSCs in Pulmonary Fibrosis Published, page-2

  1. 5 Posts.
    A super positive announcement today of 'striking effects ..a potential to be A novel treatment option for IPF...AndA Tekcyte deal confirming a high degree of likelihood that cymerus works for DFU as well.Shame about the global.market sell off but nonetheless we are green today.Surely much much better times ahead barring of course the planet being blown or the global.financial system going into melt down!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
17.0¢ 17.0¢ 16.0¢ $29.18K 176.1K

Buyers (Bids)

No. Vol. Price($)
2 66467 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 65000 1
View Market Depth
Last trade - 15.59pm 25/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.